Follow-on requirement for Zika Vaccine Project

The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) intends to negotiate on an other than full and open competition basis with Centofanti Consulting, Inc., 15 Otis Way, Los Altos, CA to complete plan of action for Zika DNA vaccine project. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.501(a)(1).

Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type of contract. This follow-on requirement will ensure salient requirements are maintained throughout project.

The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available and no substitutions are possible. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS. All responsible sources who can provide the same product may submit a response that could be considered by email to Brad Engel at brad.engel@nih.gov by the indicated response time. All information furnished must be in writing and must contain sufficient detail to allow NIAID to determine if it can meet the above unique specifications described herein. All responses received by the closing date of this solicitation will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.